Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Muscle Invasive Bladder Urothelial Carcinoma × erdafitinib × 90 days × Clear all

Sponsor

Conditions

Non-Muscle Invasive Bladder Neoplasms 4 Urinary Bladder Neoplasms 3 Glioma 3 Wilms Tumor 2 Urothelial Cancer 2 Rhabdoid Tumor 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Carcinoma, Transitional Cell 2 Xanthogranuloma, Juvenile 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1 Lymphoma 1 Histiocytic Sarcoma 1 Familial ependymoma 1 Advanced Solid Tumor 1 Acrocephalosyndactylia 1

Interventions

relatlimab 1 pembrolizumab 1 enfortumab vedotin 1 Specimen Handling 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Disulfides 1 Cystoscopy 1 Circulating Tumor DNA 1 Cell-Free Nucleic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡